Jozef Madžo
- Aging top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 7
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 21
- RNA modifications and cancer 13
- Cancer-related gene regulation 6
- Histone Deacetylase Inhibitors Research 5
- Cancer Research top 10%
-
- Viral-associated cancers and disorders 5
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- Jaroslav Jelı́nekJean‐Pierre J. IssaJan TrkaLucy A. GodleyShinji MaegawaYue LuShoudan LiangJustin T. Lee
- Cited by
- AgingHematologyMolecular Biology
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (3 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesCzechiaGermany
In The Last Decade
Jozef Madžo
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Aging 53
- Hematology 222
- Molecular Biology 1.0k
- Cancer Research 201
- Oncology 213
Countries citing papers authored by Jozef Madžo
This map shows the geographic impact of Jozef Madžo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jozef Madžo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jozef Madžo more than expected).
Fields of papers citing papers by Jozef Madžo
This network shows the impact of papers produced by Jozef Madžo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jozef Madžo. The network helps show where Jozef Madžo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jozef Madžo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 14 | |
| 7 | 2022 | 37 | |
| 8 | 2022 | 6 | |
| 9 | 2019 | 0 | |
| 10 | 2019 | 31 | |
| 11 | 2018 | 108 | |
| 12 | 2018 | 32 | |
| 13 | 2017 | 93 | |
| 14 | 2017 | 42 | |
| 15 | 2016 | 49 | |
| 16 | 2015 | 67 | |
| 17 | 2015 | 43 | |
| 18 | 2014 | 10 | |
| 19 | 2005 | 3 | |
| 20 | 2002 | 29 |
About Jozef Madžo
Jozef Madžo is a scholar working on Hematology, Aging and Molecular Biology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (13 papers), Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Cancer-related gene regulation (6 papers), Viral-associated cancers and disorders (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Aging (53 citations), Hematology (222 citations) and Molecular Biology (1.0k citations). Jozef Madžo has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include Jaroslav Jelı́nek, Jean‐Pierre J. Issa, Jan Trka, Lucy A. Godley, Shinji Maegawa, Yue Lu, Shoudan Liang, Justin T. Lee, Charly R. Good and Shoghag Panjarian. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.